• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子CXCL10通过基质金属蛋白酶-2加速肝癌中的上皮-间质转化和转移。

CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma.

作者信息

Ren Tingting, Zhu Lili, Cheng Mingliang

机构信息

Department of Biochemistry, Affiliated Hospital of Guiyang Medical College28 Guiyi Street, Guiyang 550004, Guizhou, China.

The Affiliated Baiyun Hospital of Guizhou Medical UniversityGuiyang 550004, Guizhou, China.

出版信息

Am J Transl Res. 2017 Jun 15;9(6):2824-2837. eCollection 2017.

PMID:28670372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5489884/
Abstract

Human malignant hepatocellular carcinoma (HCC) is a common tumor, which severely threatens human health and shortens longevity. The poor prognosis of HCC is primarily attributed to distant metastases. C-X-C motif chemokine 10 (CXCL10) regulates the control of several cellular and developmental processes including tumor cell proliferation, apoptosis, and cell metastasis. Previous studies have confirmed that CXCL10 functions as an oncogene in several cancers. However, the expression and biological functions of CXCL10 in HCC, especially with regard to metastasis, need further investigation. In this study, CXCL10 was found to be over expressed in invasive HCC cells and HCC clinical samples. While the over-expression of CXCL10 enhanced migration, invasion, and metastasis of HCC cells in vitro as well as in vivo, silencing of CXCL10 resulted in inhibition of HCC cell metastasis. Further, CXCL10 was found to accelerate epithelial-mesenchymal transition of HCC cells. The microarray analysis indicated that matrix metallopeptidase-2 (MMP-2) functions as a downstream factor of CXCL10. This study demonstrates that CXCL10 partakes in the metastasis of HCC by activating MMP-2 expression.

摘要

人类恶性肝细胞癌(HCC)是一种常见肿瘤,严重威胁人类健康并缩短寿命。HCC预后不良主要归因于远处转移。C-X-C基序趋化因子10(CXCL10)调控多种细胞和发育过程,包括肿瘤细胞增殖、凋亡及细胞转移。既往研究证实CXCL10在多种癌症中作为癌基因发挥作用。然而,CXCL10在HCC中的表达及生物学功能,尤其是与转移相关的功能,仍需进一步研究。本研究发现CXCL10在侵袭性HCC细胞和HCC临床样本中过表达。CXCL10的过表达增强了HCC细胞在体外及体内的迁移、侵袭和转移能力,而CXCL10沉默则导致HCC细胞转移受到抑制。此外,还发现CXCL10可加速HCC细胞的上皮-间质转化。微阵列分析表明基质金属蛋白酶-2(MMP-2)作为CXCL10的下游因子发挥作用。本研究证明CXCL10通过激活MMP-2表达参与HCC的转移。

相似文献

1
CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma.趋化因子CXCL10通过基质金属蛋白酶-2加速肝癌中的上皮-间质转化和转移。
Am J Transl Res. 2017 Jun 15;9(6):2824-2837. eCollection 2017.
2
Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.IQGAP3 在人肝癌转移和上皮-间充质转化中的作用。
J Transl Med. 2017 Aug 15;15(1):176. doi: 10.1186/s12967-017-1275-8.
3
Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.MMP-8 和 TGF-β1 之间的相互激活可刺激肝癌 EMT 及恶性进展。
Cancer Lett. 2016 Apr 28;374(1):85-95. doi: 10.1016/j.canlet.2016.02.001. Epub 2016 Feb 10.
4
HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.HEG1 通过激活 Wnt/β-catenin 信号通路促进肝癌侵袭、转移和 EMT,预示着不良预后。
Clin Sci (Lond). 2019 Jul 25;133(14):1645-1662. doi: 10.1042/CS20190225. Print 2019 Jul 31.
5
miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.miR-345通过靶向肝细胞癌中IRF1介导的mTOR/STAT3/AKT信号通路抑制肿瘤转移和上皮-间质转化。
Int J Oncol. 2017 Mar;50(3):975-983. doi: 10.3892/ijo.2017.3852. Epub 2017 Jan 17.
6
DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.DEPTOR 通过自分泌 TGFβ1 信号诱导部分上皮间质转化和转移,并与肝细胞癌的不良预后相关。
J Exp Clin Cancer Res. 2019 Jun 22;38(1):273. doi: 10.1186/s13046-019-1220-1.
7
Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition.五聚体蛋白3过表达通过驱动上皮-间质转化加速肝癌的肿瘤转移并提示预后不良。
J Cancer. 2018 Jun 23;9(15):2650-2658. doi: 10.7150/jca.25188. eCollection 2018.
8
Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.长链非编码RNA AOC4P通过增强波形蛋白降解和抑制上皮-间质转化来抑制肝细胞癌转移。
Oncotarget. 2015 Sep 15;6(27):23342-57. doi: 10.18632/oncotarget.4344.
9
GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.GP73 通过激活 TGF-β1/Smad2 信号通路促进肝癌细胞的上皮间质转化和侵袭。
Carcinogenesis. 2018 Jul 3;39(7):900-910. doi: 10.1093/carcin/bgy010.
10
TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.TAZ调节人肝细胞癌的细胞增殖和上皮-间质转化。
Cancer Sci. 2015 Feb;106(2):151-9. doi: 10.1111/cas.12587. Epub 2015 Jan 30.

引用本文的文献

1
CXCR3 inhibitors for therapeutic interventions: current status and perspectives.用于治疗干预的CXCR3抑制剂:现状与展望
Front Pharmacol. 2025 Jul 25;16:1556196. doi: 10.3389/fphar.2025.1556196. eCollection 2025.
2
Cytokine biomarkers for independent prediction of hepatocellular carcinoma prognosis.用于独立预测肝细胞癌预后的细胞因子生物标志物。
Discov Oncol. 2025 Mar 29;16(1):421. doi: 10.1007/s12672-025-02188-w.
3
CXCL10 promotes melanoma angiogenesis and tumor growth.趋化因子CXCL10促进黑色素瘤血管生成和肿瘤生长。
Anim Cells Syst (Seoul). 2024 Sep 11;28(1):453-465. doi: 10.1080/19768354.2024.2402024. eCollection 2024.
4
Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinoma.对CXCL10和MIP-3a的综合分析揭示了它们在肝细胞癌中的潜在临床应用。
Transl Oncol. 2024 Oct;48:102071. doi: 10.1016/j.tranon.2024.102071. Epub 2024 Aug 3.
5
Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.错配修复蛋白缺陷及其对结直肠癌远处转移的影响:一项综合分析。
Cancer Med. 2024 Apr;13(7):e6994. doi: 10.1002/cam4.6994.
6
Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review.炎症及其致病因素在原发性肝癌中的多功能作用:文献综述
World J Hepatol. 2023 Dec 27;15(12):1258-1271. doi: 10.4254/wjh.v15.i12.1258.
7
Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma.干扰素γ诱导蛋白-10(IP-10)及其受体在肝癌患者中的特征和临床意义。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14879-14888. doi: 10.1007/s00432-023-05265-1. Epub 2023 Aug 20.
8
Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review.基质金属蛋白酶在癌症及其各种治疗方面的作用洞察:综述
Front Mol Biosci. 2022 Sep 29;9:896099. doi: 10.3389/fmolb.2022.896099. eCollection 2022.
9
(Dis)similarities between the Decidual and Tumor Microenvironment.蜕膜与肿瘤微环境之间的(不)相似性。
Biomedicines. 2022 May 4;10(5):1065. doi: 10.3390/biomedicines10051065.
10
Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.CXC趋化因子在肝细胞癌微环境中作为生物标志物和潜在治疗靶点的功能。
Transl Cancer Res. 2021 May;10(5):2169-2187. doi: 10.21037/tcr-21-127.

本文引用的文献

1
RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.RIP1上调通过激活AKT/Bcl-2/BAX信号通路促进肿瘤进展,并预示肝癌术后预后不良。
Tumour Biol. 2016 Nov;37(11):15305-15313. doi: 10.1007/s13277-016-5342-1. Epub 2016 Oct 4.
2
BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma.BCAT1促进肝细胞癌中肿瘤细胞的迁移和侵袭。
Oncol Lett. 2016 Oct;12(4):2648-2656. doi: 10.3892/ol.2016.4969. Epub 2016 Aug 8.
3
Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy.低剂量5-氟尿嘧啶化疗后,肝癌干细胞样细胞增多。
Oncol Lett. 2016 Oct;12(4):2511-2516. doi: 10.3892/ol.2016.4975. Epub 2016 Aug 8.
4
Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.miR-95-3p 在肝癌中的上调通过靶向 p21 表达促进肿瘤发生。
Sci Rep. 2016 Oct 4;6:34034. doi: 10.1038/srep34034.
5
miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7.微小RNA-935通过靶向SOX7促进肝癌细胞增殖和迁移。
Oncol Res. 2017 Mar 13;25(3):427-435. doi: 10.3727/096504016X14747300207374. Epub 2016 Sep 30.
6
Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.前折叠蛋白1通过抑制细胞周期蛋白A的表达促进上皮-间质转化和肺癌进展。
Oncogene. 2017 Feb 16;36(7):885-898. doi: 10.1038/onc.2016.257. Epub 2016 Oct 3.
7
eIF5B increases ASAP1 expression to promote HCC proliferation and invasion.真核生物翻译起始因子5B(eIF5B)增加ASAP1表达以促进肝癌细胞增殖和侵袭。
Oncotarget. 2016 Sep 20;7(38):62327-62339. doi: 10.18632/oncotarget.11469.
8
Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.缓激肽通过瞬时受体电位阳离子通道蛋白7(TRPM7)和基质金属蛋白酶2(MMP2)促进肝癌细胞的迁移和侵袭。
Exp Cell Res. 2016 Nov 15;349(1):68-76. doi: 10.1016/j.yexcr.2016.09.022. Epub 2016 Sep 30.
9
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma.PDK1表达与肝细胞癌临床病理特征及预后的相关性
Onco Targets Ther. 2016 Sep 9;9:5597-602. doi: 10.2147/OTT.S110646. eCollection 2016.
10
CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.CXCL10/CXCR3 轴通过 PI3K/AKT 通路依赖性 MMPs 产生促进胃癌的侵袭。
Biomed Pharmacother. 2016 Aug;82:479-88. doi: 10.1016/j.biopha.2016.04.069. Epub 2016 Jun 1.